Vertex Pharma Shares Rise On Better-than-expected Results

By Wallace WitkowskiMarketWatch Pulse

Vertex Pharmaceuticals Inc. shares rallied in the extended session Wednesday after the company topped Wall Street expectations for the quarter. Shares of Vertex jumped 6.2% to $127.50. The company reported an adjusted loss of 13 cents a share on revenue of $309.8 million. Analysts surveyed by FactSet had estimated a loss of 46 cents a share on revenue of $246.2 million.

Copyright © 2015 MarketWatch, Inc.

Continue Reading Below